Buffalo, NY USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

For Some Lung Cancer Patients Receiving SBRT, One and Done Approach Works Best


A new study led by Anurag Singh, MD, of Roswell Park Cancer Institute and presented at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting suggests that a single high-intensity SBRT dose can be as effective as three slightly...
27-Sep-2016 10:05 AM EDT Add to Favorites

E-Cigarette Research: Flavorings and Higher Voltage Increase Toxicity of E-Cigs

BUFFALO, N.Y. — Roswell Park Cancer Institute scientists report that several flavorings added to electronic cigarettes impact the toxicity of the devices and that, among the tested flavors, strawberry was the most toxic. The researchers also...
19-Sep-2016 1:05 PM EDT Add to Favorites

Secrets of Age-Related Diseases May Lie in Cellular Targets Identified by Roswell Park/Everon Team

New insights on age-related diseases may hold the key to both delaying aging and, in the process, reducing the occurrence of diseases including cancer. These findings have been reported by a team from Roswell Park Cancer Institute and Everon...
1-Aug-2016 3:05 PM EDT Add to Favorites

Roswell Park Findings Will Help Clinicians Select Best Therapy for Patients with Advanced Liver Cancer

New research from Roswell Park Cancer Institute offers clinicians treating patients with advanced liver cancer a way of determining which patients may benefit most from the targeted therapy sorafenib.
28-Jul-2016 1:05 PM EDT Add to Favorites

Roswell Park-Led Study: Photoacoustic Imaging Is Promising Option for Noninvasive Monitoring of Prostate Cancer


While active surveillance is often recommended for patients with nonaggressive prostate cancer to reduce unnecessary treatment, the challenge for clinicians is to monitor and distinguish early-stage tumors from advanced cancers. A team of scientists...
14-Jul-2016 8:05 AM EDT Add to Favorites

Nivolumab Extends Survival for Patients with Advanced Kidney Cancer Treated Beyond Disease Progression

In a large randomized study, the immunotherapy drug nivolumab, a checkpoint inhibitor, was shown to be a safe and effective therapy for kidney cancer even in patients who continued treatment after their disease progressed.
4-Jun-2016 1:05 PM EDT Add to Favorites

Increase in Obesity Among Pediatric Hodgkin Lymphoma Patients May be Linked to Disease Relapse

A study led by researchers at Roswell Park Cancer Institute and Columbia University Medical Center used advanced imaging methods to evaluate obesity, and suggests a relationship between obesity and disease relapse.
4-Jun-2016 7:30 AM EDT Add to Favorites

Cancer Diagnosed More Often in Patients with Primary Immunodeficiency Diseases

Roswell Park researchers evaluated the overall and site-specific incidence of cancer among patients registered in USIDNET, and found increased cancer incidence rates, especially in lymphomas, among patients with primary immunodeficiency diseases.
4-Jun-2016 1:05 PM EDT Add to Favorites

Our Experts on Newswise

Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch

22-Sep-2016 3:05 PM EDT

Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk

27-Oct-2015 5:05 PM EDT

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

Chat now!